Journal article
An ethical analysis of public attitudes towards controlled human infection studies in Singapore: acceptability and payment
- Abstract:
- Singapore is conducting its first controlled human infection (CHI) study, and is administering SARS-CoV-2 as the challenge agent. Ahead of this study, we conducted a survey to assess public perceptions in Singapore of CHI studies in general and with SARS-CoV-2, and the ethical issues they raise, including those around payments to research participants. Overall, there was large support for challenge studies in Singapore, suggesting they could obtain a social license. However, a minority strongly disagreed, and most respondents reported limited pre-survey knowledge about CHI studies. Importantly, Singaporeans support a higher incentive model of payment than is usually employed in challenge study research. They support either a Market Model or a Payment for Risk Model. There was most support for paying participants the highest rate offered—in our study, it was $SGD30 per hour. These results were broadly in line with a similar study in the UK, despite the latter having notably lower reported levels of public trust and, most recently, a highly criticized response to COVID-19. As such, general support for CHI studies may not be a direct function of background confidence in public or biomedical institutions but reflect other factors such as their intrinsic value and importance. More direct cross-cultural research in different contexts concerning attitudes towards CHI studies could help shed light on the extent that localized factors such as culture, history, and infrastructure affect both their acceptability and attitudes towards participant payment.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 863.8KB, Terms of use)
-
- Publisher copy:
- 10.1007/s41649-024-00335-z
Authors
+ Wellcome Trust
More from this funder
- Funder identifier:
- https://ror.org/029chgv08
- Grant:
- 203132/Z/16/Z
+ UK Research and Innovation
More from this funder
- Funder identifier:
- https://ror.org/001aqnf71
- Grant:
- AH/V006819/1
- Publisher:
- Springer Nature
- Journal:
- Asian Bioethics Review More from this journal
- Publication date:
- 2025-05-30
- Acceptance date:
- 2024-11-04
- DOI:
- EISSN:
-
1793-9453
- ISSN:
-
1793-8759
- Language:
-
English
- Keywords:
- Pubs id:
-
2122513
- Local pid:
-
pubs:2122513
- Deposit date:
-
2025-05-09
Terms of use
- Copyright holder:
- Young et al
- Copyright date:
- 2025
- Rights statement:
- ©2025 The Authors. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record